On May 11, 2026, Medical Data Vision Co., Ltd. will issue 1 Class A preferred share by third-party allotment to Nippon Life Insurance Company at 17,249,077,446 yen, and simultaneously reduce capital stock and capital surplus to secure funds for share buyback.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3902","jir_company_name":"Medical Data Vision Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-03-24","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/3902-20260324-02.pdf","jir_short_summary":"On May 11, 2026, Medical Data Vision Co., Ltd. will issue 1 Class A preferred share by third-party allotment to Nippon Life Insurance Company at 17,249,077,446 yen, and simultaneously reduce capital stock and capital surplus to secure funds for share buyback.","jir_summary":"### Overview of Capital Policy\nMedical Data Vision Co., Ltd. has resolved, as of May 11, 2026, to issue 1 Class A preferred share to Nippon Life Insurance Company by third-party allotment at 17,249,077,446 yen. Concurrently, the company will reduce capital stock and capital surplus by 8,624,538,723 yen each and transfer the amounts to other capital surplus through capital reduction. This capital increase and reduction are scheduled to take place after a share consolidation on the same day. The allottee aims to make the company a wholly owned subsidiary, securing funds and distributable amounts for share buyback. The Class A preferred shares carry no voting rights, so there will be no dilution of ordinary shares' voting rights.\n\n### Shareholder Composition and Future Outlook\nFollowing this third-party allotment, Nippon Life Insurance Company will hold 100% of the Class A preferred shares, while ordinary shares will be held 55.56% by Nippon Life Insurance Company and 44.44% by SBI Holdings. Due to the share consolidation, other shareholders will hold fractional shares, effectively leaving only the allottee and SBI Holdings as shareholders. This capital increase and reduction are not expected to impact business performance, and the use of funds is deemed reasonable. The allottee\u2019s payment funds have been confirmed to be covered by own capital.","jir_financial_highlights":"Number of shares offered: 1 Class A preferred share (Unknown)\nPayment amount: 17,249,077,446 yen (Unknown)\nProceeds (net amount): 17,186,077,446 yen (Unknown)\nCapital stock reduction amount: 8,624,538,723 yen (Unknown)\nCapital surplus reduction amount: 8,624,538,723 yen (Unknown)","jir_category":"","jir_hashtags":"#MedicalDataVisionCoLtd, #CapitalPolicy, #ThirdPartyAllotmentCapitalIncrease","jir_key_figures":"Number of Class A preferred shares issued: 1 share\nPayment amount: 17,249,077,446 yen\nCapital stock reduction amount: 8,624,538,723 yen","jir_meta_title":"Medical Data Vision Executes Third-Party Allotment Capital Increase of 17,249 Million Yen and Capital Stock Reduction","jir_meta_description":"Medical Data Vision Co., Ltd. will issue 1 Class A preferred share to Nippon Life Insurance Company at 17,249,077,446 yen on May 11, 2026, while reducing capital stock and capital surplus to secure funds for share buyback.","jir_og_title":"Medical Data Vision Announces Third-Party Allotment Capital Increase and Capital Stock Reduction","jir_og_description":"A capital policy aimed at making the company a wholly owned subsidiary through a 17,249 million yen third-party allotment to Nippon Life Insurance Company and capital stock reduction.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17052,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-36105","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n